Integrated DNA Technologies (IDT) is investing in next generation sequencing (NGS) research assays from Invitae Corporation under the trademarked name Archer. Invitae’s NGS research assays have been “foundational in researching novel cancer fusions” and will help IDT labs “uncover biomarkers,”…